Referent: Dr. Patrick Baumhof
Moderation: Prof. Dr. Olivia Merkel (LMU)
Over the past years mRNA based therapeutics moved into the focus of drug development. With mRNA based vaccines in the market now the field is looking towards broader application of the technology. As a pioneer in the field CureVac has discovered several main principles that are relevant in development. The presentation discusses different applications of mRNA in drug development.
Patrick Baumhof ist Senior Vice President Technology bei CureVac (Tübingen).
Anmelde-Info
Für die Teilnahme ist eine Anmeldung unter info@cas.lmu.de erforderlich.